145 related articles for article (PubMed ID: 12188267)
1. Evaluation of the time window for Resovist-enhanced T2-weighted MRI of the liver.
Reimer P; Müller M; Marx C; Balzer T
Acad Radiol; 2002 Aug; 9 Suppl 2():S336-8. PubMed ID: 12188267
[No Abstract] [Full Text] [Related]
2. [Overview of MRI contrast media. The case of endorem].
Duroux M
Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.
Saini S; Edelman RR; Li W; Petersein J; Hahn PF
Acad Radiol; 1996 Aug; 3 Suppl 2():S409-12. PubMed ID: 8796616
[No Abstract] [Full Text] [Related]
4. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
5. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
Macarini L; Marini S; Murrone M; Ettorre GC
Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693
[TBL] [Abstract][Full Text] [Related]
6. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
7. Overview of contrast enhancement with iron oxides.
Frija G; Clément O; de Kerviler E
Invest Radiol; 1994 Jun; 29 Suppl 2():S75-7. PubMed ID: 7928276
[No Abstract] [Full Text] [Related]
8. [MR contrast agent: resovist (SH U 555A)].
Nakajima H; Ichikawa T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
[No Abstract] [Full Text] [Related]
9. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.
Frija G; Clément O; Le Guen O; Cuénod CA; Siauve N; Benderbous S
Acad Radiol; 1996 Aug; 3 Suppl 2():S299-300. PubMed ID: 8796586
[No Abstract] [Full Text] [Related]
10. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.
Kopp AF; Laniado M; Dammann F; Stern W; Grönewäller E; Balzer T; Schimpfky C; Claussen CD
Radiology; 1997 Sep; 204(3):749-56. PubMed ID: 9280254
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
12. Relaxation effects of clustered particles.
Tanimoto A; Oshio K; Suematsu M; Pouliquen D; Stark DD
J Magn Reson Imaging; 2001 Jul; 14(1):72-7. PubMed ID: 11436217
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide particle-enhanced hepatic MRI: differentiation of hepatic lesions using dual echo field echo sequences without obtaining precontrast images.
Kuwatsuru R; Ito S; Akamatsu M; Maehara T
Acad Radiol; 2002 Aug; 9 Suppl 2():S473-5. PubMed ID: 12188312
[No Abstract] [Full Text] [Related]
14. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
15. MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.
Clement O; Rety F; Cuenod CA; Siauve N; Carnot F; Bordat C; Siche M; Frija G
Acad Radiol; 1998 Apr; 5 Suppl 1():S170-2; discussion S183-4. PubMed ID: 9561073
[No Abstract] [Full Text] [Related]
16. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects.
Clément O; Siauve N; Cuénod CA; Frija G
Top Magn Reson Imaging; 1998 Jun; 9(3):167-82. PubMed ID: 9621405
[TBL] [Abstract][Full Text] [Related]
17. State of the art in diagnostic liver imaging.
Lamprecht A; Wagner B
Eur Radiol; 2004 Jan; 14 Suppl 1():C2-3. PubMed ID: 15113057
[No Abstract] [Full Text] [Related]
18. Clinical results with Resovist: a phase 2 clinical trial.
Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
[TBL] [Abstract][Full Text] [Related]
19. Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Okada T; Sasaki F; Kamiyama T; Nakagawa T; Nakanishi K; Kobayashi R; Itoh T; Ota S; Todo S
J Pediatr Surg; 2005 Mar; 40(3):E21-5. PubMed ID: 15793708
[TBL] [Abstract][Full Text] [Related]
20. Preliminary clinical experience with AMI 227.
McLachlan SJ; Morris M; Lucas MA; Baum LM
Acad Radiol; 1996 Aug; 3 Suppl 2():S295-6. PubMed ID: 8796584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
